Who owns the AVANCE CLINICAL THE CRO FOR BIOTECHS trademark?

The AVANCE CLINICAL THE CRO FOR BIOTECHS trademark is owned by Avance Clinical Pty Ltd.

What class is the AVANCE CLINICAL THE CRO FOR BIOTECHS trademark registered in?

The AVANCE CLINICAL THE CRO FOR BIOTECHS trademark is registered in Class 035 (Advertising, business management & retail services), Class 042 (Scientific, technology & SaaS services).

What is the serial number for AVANCE CLINICAL THE CRO FOR BIOTECHS?

The USPTO serial number for AVANCE CLINICAL THE CRO FOR BIOTECHS is 79401298.

What is the registration number for AVANCE CLINICAL THE CRO FOR BIOTECHS?

AVANCE CLINICAL THE CRO FOR BIOTECHS is registered under USPTO registration number 7988932.

AVA

USPTO Trademark Record

REGISTERED

AVANCE CLINICAL THE CRO FOR BIOTECHS

SN 79401298·Reg 7988932·Filed May 24, 2024

Owner Avance Clinical Pty Ltd

Advertising; business management, organization and administration; office functions.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

AVANCE CLINICAL THE CRO FOR BIOTECHS (Serial No. 79401298), Registration No. 7988932, is a registered US trademark filed on May 24, 2024 by Avance Clinical Pty Ltd. This trademark covers Class 035 (Advertising, business management & retail services), Class 042 (Scientific, technology & SaaS services).

early section 8: October 21, 2031

Mark Intelligence

AVANCE CLINICAL THE CRO FOR BIOTECHS (Reg. #7988932) is a registered US trademark that has been protecting its owner, Avance Clinical Pty Ltd, since 2024. The mark covers Class 035 (Advertising, business management & retail services) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Advertising; business management, organization and administration; office functions.; Scientific and technological servi.... The mark faced 4 opposition proceedings during prosecution.

FILED

May 24, 2024

SERIAL

79401298

REG#

7988932

REGISTERED

Oct 21, 2025

Owner

Applicant

Avance Clinical Pty Ltd

Entity

Corporation (Foreign)

Address

Level 22, 91 King William Street, Adelaide SA 5000

Country

Attorney

NameDavid L. May

Law firm

David L. May Nixon Peabody LLP

Docket

065170-96

Address

799 9th Street, NW, Suite 500, Washington, DC 20001, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateMay 24, 2024

Serial Number79401298

Registration No.7988932

Registration DateOct 21, 2025

Status DateOct 21, 2025

Published for OppositionSep 02, 2025

Mark TypeStandard characters

Attorney Docket065170-96

Status DescriptionLive and registered

Filing Signals

FILED

2024

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 4× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 035Advertising, business management & retail services

US codes: 100, 101, 102

Advertising; business management, organization and administration; office functions.

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

34 events

CHANGE OF NAME/ADDRESS REC'D FROM IB

Jul 23, 2026

CHANGE OF NAME/ADDRESS REC'D FROM IB

FINAL DECISION TRANSACTION PROCESSED BY IB

May 28, 2026

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

May 07, 2026

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

May 07, 2026

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jan 21, 2026

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Jan 15, 2026

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Dec 31, 2025

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Dec 31, 2025

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Oct 21, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Oct 21, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Sep 02, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 02, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 27, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Jul 28, 2025

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Jul 28, 2025

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jul 28, 2025

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Jul 28, 2025

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 28, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

FINAL REFUSAL WRITTEN

May 29, 2025

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

May 29, 2025

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

May 29, 2025

NOTIFICATION OF FINAL REFUSAL EMAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 06, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 06, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

May 06, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Jan 25, 2025

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Jan 04, 2025

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jan 04, 2025

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Dec 17, 2024

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Dec 16, 2024

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Dec 09, 2024

ASSIGNED TO EXAMINER

CHANGE OF NAME/ADDRESS REC'D FROM IB

Sep 13, 2024

CHANGE OF NAME/ADDRESS REC'D FROM IB

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 06, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

Aug 06, 2024

APPLICATION FILING RECEIPT MAILED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Aug 01, 2024

SN ASSIGNED FOR SECT 66A APPL FROM IB

AVANCE CLINICAL THE CRO FOR BIOTECHS

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Avance Clinical Pty Ltd

Other Marks in Class 035 — Advertising, business management & retail services

Other Marks by David L. May

Resources

Company